Autosomal recessive nonsyndromic deafness (ARNSD) is characterized by a high degree of genetic heterogeneity, with reported mutations in 58 different genes. This study was designed to detect ...
The autosomal dominant optic atrophy (ADOA) treatment market is experiencing steady expansion, driven by growing disease awareness, advancements in diagnosis, and breakthrough therapies from key ...
A total of 23 patients, from the Italian Association of Pediatric Hematology and Oncology (AIEOP)-Italian Network of Primary Immunodeficiencies (IPINET) database, were selected for this study. They ...
"Autosomal Dominant Optic Atrophy Market Insight, Epidemiology And Market Forecast - 2034"The autosomal dominant optic atrophy (ADOA) treatment market is experiencing steady expansion, driven by ...